The pivotal REACH trial successfully met its primary endpoint by showing that patients treated with MabThera in combination with the current standard chemotherapy were able to significantly extend
Cell-Freeze is used for cryogenic temperature applications as low as -196°C for storage, preservation and transfer. Cell-Freeze containers have a uniquely designed proprietary membrane port with attached cap
The ProFUSE demineralized bone scaffold is a porous, malleable allograft that can be used with Alphatec Spine’s Novel spacers and AlphaGRAFT structural allografts. The ProFUSE product provides a
Analysis of the data indicates that once- daily oral dosing of linaclotide, across a range of doses, significantly reduced abdominal pain and significantly improved constipation symptoms in patients
According to the company, oral administration of RDEA119 was shown to significantly reduce damage to colonic tissue and disease activity in dextran sulfate sodium – induced chronic colitic
Previous Phase I and proof of concept studies of ganaxolone have demonstrated safety and efficacy in refractive epilepsy. The ganaxolone program currently consists of four clinical studies, one
The National Comprehensive Cancer Network (NCCN) studies will evaluate Abraxane in the treatment of breast, non-small cell lung, head and neck, melanoma and ovarian cancers. The clinical research
According to the company, these handpieces expand the capabilities of the Fraxel re:pair laser system, providing physicians with a complete skin resurfacing and surgical treatment option. As part
While there is no finding that Lilly has violated any provision of the state laws under which the investigations were conducted, the company said that it will pay
Medelis Europe delivers complete oncology drug development services from preclinical through Phase III. The European, US and Asian sponsors looking to bring drugs to the US and European
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.